Last updated: July 14, 2025
Sponsor: Institute of Dermatology, Thailand
Overall Status: Completed
Phase
N/A
Condition
Aging
Treatment
Epidermal Growth Factor
Clinical Study ID
NCT05724589
008/2565
Ages 40-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Thai
Mild to moderate facial skin condition, as measured by 1-2 points on thehyperpigmentation status scale or 2-3 points on the wrinkle severity grading scale.
Exclusion
Exclusion Criteria:
Use of lotions or skin care products containing ingredients such as vitamin A/C,hydroquinone, or anti-aging agents.
Sunbathing
Hypersensitivity to serum components
Pregnancy and breast-feeding
Active skin diseases such as eczema or atopic dermatitis at the application site
Study Design
Total Participants: 28
Treatment Group(s): 1
Primary Treatment: Epidermal Growth Factor
Phase:
Study Start date:
January 30, 2023
Estimated Completion Date:
December 12, 2024
Study Description
Connect with a study center
Institute of Dermatology
Bangkok, 10400
ThailandSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.